Insider Stock Trading History of Berkle Sheldon


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Berkle Sheldon since year 2005. The trader's CIK number is 1350078. At the time of this reporting, Berkle Sheldon is the President and CEO of Altus Pharmaceuticals Inc. . (stock ticker symbol ALTU). See this page for all insider trading activities at Altus Pharmaceuticals Inc. .


Stock purchases, sales, and option exercises reported by insider Berkle Sheldon since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2007-12-13 ALTU Altus Pharmaceuticals Inc. Option Ex 32,000 3.92 125,440
2007-08-01 ALTU Altus Pharmaceuticals Inc. Sale 3,250 9.89 32,142
2007-08-01 ALTU Altus Pharmaceuticals Inc. Option Ex 3,250 3.92 12,740
2007-07-19 ALTU Altus Pharmaceuticals Inc. Sale 8,000 11.54 92,320
2007-07-18 ALTU Altus Pharmaceuticals Inc. Sale 11,500 11.54 132,710
2007-07-19 ALTU Altus Pharmaceuticals Inc. Option Ex 8,000 3.92 31,360
2007-07-18 ALTU Altus Pharmaceuticals Inc. Option Ex 11,500 3.92 45,080
2007-04-02 ALTU Altus Pharmaceuticals Inc. Sale 9,750 15.03 146,542
2007-04-02 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2007-03-01 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2007-03-01 ALTU Altus Pharmaceuticals Inc. Sale 9,750 15.68 152,880
2007-02-01 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2007-02-01 ALTU Altus Pharmaceuticals Inc. Sale 9,750 18.25 177,937
2007-01-03 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2007-01-03 ALTU Altus Pharmaceuticals Inc. Sale 9,750 18.88 184,080
2006-12-22 ALTU Altus Pharmaceuticals Inc. Option Ex 8,000 3.92 31,360
2006-12-20 ALTU Altus Pharmaceuticals Inc. Sale 6,500 20.07 130,455
2006-12-20 ALTU Altus Pharmaceuticals Inc. Option Ex 6,500 3.92 25,480
2006-12-01 ALTU Altus Pharmaceuticals Inc. Sale 9,750 17.87 174,232
2006-12-01 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2006-11-01 ALTU Altus Pharmaceuticals Inc. Option Ex 9,750 3.92 38,220
2006-11-01 ALTU Altus Pharmaceuticals Inc. Sale 9,750 16.07 156,682

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Berkle Sheldon (President and CEO of Altus Pharmaceuticals Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.